PE31195A1 - Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene - Google Patents
Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contieneInfo
- Publication number
- PE31195A1 PE31195A1 PE1994255110A PE25511094A PE31195A1 PE 31195 A1 PE31195 A1 PE 31195A1 PE 1994255110 A PE1994255110 A PE 1994255110A PE 25511094 A PE25511094 A PE 25511094A PE 31195 A1 PE31195 A1 PE 31195A1
- Authority
- PE
- Peru
- Prior art keywords
- preparation
- pharmaceutical composition
- piridin
- ilo
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE31195A1 true PE31195A1 (es) | 1995-10-18 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1994255110A PE31195A1 (es) | 1993-05-21 | 1994-11-18 | Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (fr) |
| JP (1) | JPH08510455A (fr) |
| CN (1) | CN1126473A (fr) |
| AU (1) | AU6928794A (fr) |
| BG (1) | BG100154A (fr) |
| CA (1) | CA2162921A1 (fr) |
| CZ (1) | CZ305195A3 (fr) |
| FI (1) | FI955587A0 (fr) |
| GB (1) | GB9310635D0 (fr) |
| HU (1) | HUT73790A (fr) |
| IL (1) | IL109703A0 (fr) |
| NO (1) | NO954681D0 (fr) |
| OA (1) | OA10195A (fr) |
| PE (1) | PE31195A1 (fr) |
| PL (1) | PL311702A1 (fr) |
| SK (1) | SK142495A3 (fr) |
| TW (1) | TW279866B (fr) |
| WO (1) | WO1994027989A1 (fr) |
| ZA (1) | ZA943494B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2170874A1 (fr) * | 1993-09-30 | 1995-04-06 | Minoru Okada | Derive d'azole et composition pharmaceutique le contenant |
| WO1996014090A1 (fr) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprenant des carbazoles et des cyclodextrines |
| WO1996026927A1 (fr) * | 1995-03-01 | 1996-09-06 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'imidazole et composition medicinale a base desdits derives |
| WO1998037070A1 (fr) * | 1997-02-21 | 1998-08-27 | Takeda Chemical Industries, Ltd. | Composes a anneaux condenses, leur procede de production et leur utilisation |
| MY134929A (en) | 2000-11-17 | 2008-01-31 | Takeda Pharmaceutical | Novel imidazole derivatives, production method thereof and use thereof |
| EP1344777B1 (fr) | 2000-11-20 | 2011-03-16 | Takeda Pharmaceutical Company Limited | Derives de l'imidazole, leur procede de preparation et leur application |
| EP1348706B1 (fr) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Derives thiazole substitues porteurs de groupes 3-pyridyl, procede d'elaboration et leur utilisation |
| BRPI0611705A2 (pt) * | 2005-06-24 | 2016-11-16 | Lilly Co Eli | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto |
| GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| DK2445903T3 (da) | 2009-06-26 | 2014-06-23 | Novartis Ag | 1,3-Disubstituerede imidazolidin-2-on-derivater som CYP17-inhibitorer |
| EP2531029B1 (fr) * | 2010-02-04 | 2016-10-19 | Radius Health, Inc. | Modulateurs sélectifs du récepteur des androgènes |
| ME02474B (fr) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Schémas thérapeutiques |
| KR101594660B1 (ko) | 2010-08-04 | 2016-02-16 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
| WO2012035078A1 (fr) | 2010-09-16 | 2012-03-22 | Novartis Ag | Inhibiteurs de la 17α-hydroxylase/c17,20-lyase |
| BR112013007685B1 (pt) | 2010-09-28 | 2021-11-09 | Radius Pharmaceuticals, Inc | Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto |
| CN103649073B (zh) | 2011-04-28 | 2016-04-13 | 诺瓦提斯公司 | 17α-羟化酶/C17,20-裂合酶抑制剂 |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| US20160022606A1 (en) | 2013-03-14 | 2016-01-28 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| EP4035664A3 (fr) | 2014-03-28 | 2022-11-30 | Duke University | Traitement du cancer faisant intervenir des modulateurs sélectifs des récepteurs des strogènes |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| WO2016040896A1 (fr) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions et méthodes de traitement d'un carcinome de la prostate |
| RU2769527C2 (ru) | 2016-06-22 | 2022-04-01 | Эллипсес Фарма Лтд | Способы лечения ar+ рака молочной железы |
| CA3044812A1 (fr) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Compositions pharmaceutiques de 5-hydroxy-2-methylnaphtalene-1, 4-dione |
| KR102322802B1 (ko) | 2017-01-05 | 2021-11-04 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/fr not_active Application Discontinuation
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/fr not_active Abandoned
- 1994-05-19 EP EP94917647A patent/EP0699196A1/fr not_active Withdrawn
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/fi not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08510455A (ja) | 1996-11-05 |
| PL311702A1 (en) | 1996-03-04 |
| NO954681L (no) | 1995-11-20 |
| EP0699196A1 (fr) | 1996-03-06 |
| TW279866B (fr) | 1996-07-01 |
| AU6928794A (en) | 1994-12-20 |
| IL109703A0 (en) | 1994-08-26 |
| OA10195A (en) | 1996-12-18 |
| GB9310635D0 (en) | 1993-07-07 |
| FI955587A (fi) | 1995-11-20 |
| HUT73790A (en) | 1996-09-30 |
| NO954681D0 (no) | 1995-11-20 |
| CN1126473A (zh) | 1996-07-10 |
| ZA943494B (en) | 1995-01-23 |
| CA2162921A1 (fr) | 1994-12-08 |
| WO1994027989A1 (fr) | 1994-12-08 |
| HU9503321D0 (en) | 1996-01-29 |
| BG100154A (en) | 1996-07-31 |
| CZ305195A3 (en) | 1996-06-12 |
| SK142495A3 (en) | 1996-06-05 |
| FI955587A0 (fi) | 1995-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE31195A1 (es) | Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene | |
| GB1289224A (fr) | ||
| AR247402A1 (es) | Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos | |
| Hubert et al. | A Novel Reductive Cyclization of Imides | |
| MY123467A (en) | Preparation of sterically hindered amine ethers | |
| Elion et al. | The direct thiation of uracils | |
| KR890014470A (ko) | 카르바펜엠 중간체의 제조방법 | |
| NO814312L (no) | Fremgangsmaate for fremstilling av substituerte aromatiske organiske forbindelser | |
| PE20011078A1 (es) | PROCEDIMIENTO DE OBTENCION DE LOS DERIVADOS DE DIBENZO [b, f] AZEPINA | |
| AR246523A1 (es) | Procedimiento para preparar acidos 1,3,4,9-tetra-hidropirano¡3,4-b¿indol-1-aceticos sustituidos. | |
| PE20001486A1 (es) | Compuestos etereos anular de 7 a 14 miembros como inhibidores de proteasas | |
| ATE22065T1 (de) | Alkan- und alkenderivate und ihre herstellung und verwendung. | |
| ES8404679A1 (es) | Procedimiento para preparar un derivado de nitroimidazol. | |
| Corey et al. | Synthetic imino analogs of Cecropia juvenile hormones as potentiators of juvenile hormone activity | |
| US3968112A (en) | Synthesis of penniclavine and elymoclavine | |
| US2606914A (en) | delta8(9)14-androstadienes and method of preparing the same | |
| ES2032809T3 (es) | Metodo para producir un compuesto de 7-bromo-b-carbolina. | |
| CN114349656B (zh) | 一种酰肼类化合物的制备方法 | |
| ES2034537T3 (es) | Procedimiento para la obtencion de derivados del acido 5-(n-3,4,5,6-tetrahidroftalimido)-canimico. | |
| ES447737A1 (es) | Procedimiento para la preparacion de 1,4-benzodiazepinas sustituidas en posicion 2. | |
| MX3153E (es) | Procedimiento para la preparacion de 4 - fenil - imidazolinas sustituidas | |
| Barltrop et al. | Hydroxypyrylium photochemistry. A new intermediate | |
| ES272982A1 (es) | Un procedimiento de prepaciën de derivados alcohilados en posiciën 2-alfa de la 19 -nortestosterona | |
| US4082753A (en) | Penniclavine acetonide | |
| KR880000462A (ko) | 안드로스트-4-엔-3,17-디온의 메틸렌 유도체 및 그의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |